ISMI Introduces a Radiologist-Led Full-Body MRI Program Focused on Diagnostic Clarity and Long-Term Health Planning

ISMI offers a radiologist-led Full-Body MRI in Montreal to identify life-saving findings, detect health risks, and support ...

Koelis Announces Designated CPT I Codes for Fusion Biopsy and Transperineal Biopsy in Prostate Cancer Diagnosis

Koelis, SAS (“Koelis” or the “Company”, a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer interventions, recently announced that the Centers for Medicare & Medicaid ...
The Caledonian-Record

Koelis Announces Designated CPT I Codes for Fusion Biopsy and Transperineal Biopsy in Prostate ...

Koelis, SAS (“Koelis” or the “Company”, a leader and innovator in MRI-ultrasound fusion guidance for prostate cancer ...

Treatment developed for advanced prostate cancer that could eliminate severe side effects

Researchers at Case Western Reserve University have developed a treatment for advanced prostate cancer that could eliminate a ...
TipRanks on MSN

Profound Medical’s TULSA-PRO marks first commercial case at Johns Hopkins

Profound Medical ( ($TSE:PRN) ) has shared an announcement. Profound Medical announced that The Johns Hopkins Hospital has performed its first ...

Johns Hopkins Medicine Treats First Commercial TULSA-PRO® Case

Accordingly, it is not surprising that a leading institution such as Johns Hopkins Medicine is at the forefront of this trend. John Hopkins University was an early participant in the clinical ...